Hepatitis Antigen Tests (HBsAg, HBeAg, HCV Core Antigen): What They Detect and What They Cannot

Key takeaways

• "Hepatitis antigen test" is not one test. HBsAg, HBeAg and HCV core antigen answer different questions.
• Antigen tests show current virus, not immunity or past infection. Antibody tests answer those questions.
• Hepatitis A, D and E are not diagnosed by routine antigen testing in most Indian laboratories, antibody or PCR tests are used.
• A negative result within the window period can be misleading. If exposure was recent, repeat testing is needed.
• No result should be self-interpreted. The doctor who ordered the test interprets it alongside symptoms, liver enzymes (SGPT/SGOT) and risk history.

At a glance

Also known as

• HBsAg test, "Australia antigen" test (older term for HBsAg)
• Hepatitis B test, "hepatitis ka test"
• HBeAg, hepatitis B e antigen
• HCV Ag, hepatitis C core antigen test
• Often bundled into a "hepatitis profile" or "viral marker" panel, frequently ordered with SGPT (ALT) and SGOT (AST)

What a hepatitis antigen test is

Hepatitis viruses carry proteins called antigens. When a virus is actively present in the blood, laboratory assays can detect these proteins directly.

The three antigen tests used in routine care are distinct:

• HBsAg: a protein on the surface of the hepatitis B virus. A reactive HBsAg indicates current hepatitis B infection, it does not by itself tell you whether the infection is acute or chronic.
• HBeAg: a marker linked to higher viral replication in hepatitis B. HBeAg is used for staging and monitoring people already known to have hepatitis B, not for screening.
• HCV core antigen: detects hepatitis C virus protein. This test is not universally available and is not a substitute for HCV RNA (PCR) where PCR is accessible.

Importantly, there is no widely used "hepatitis antigen test" that covers all five hepatitis viruses at once. The older content suggesting a single test detects hepatitis A, B, C, D and E is incorrect.

Why a hepatitis antigen test is done

• To investigate jaundice, persistently raised SGPT/SGOT, or unexplained fatigue with abdominal discomfort
• To screen before surgery, dialysis, chemotherapy or immunosuppressive treatment, since hepatitis B can reactivate
• Antenatal screening, so that a newborn of an HBsAg-positive mother receives timely birth-dose vaccine and immunoglobulin
• Screening blood and organ donors
• Follow-up of known hepatitis B, where HBsAg and HBeAg help describe the phase of infection
• After a needle-stick or other blood exposure, as part of a structured testing schedule

Who should get this test

• Anyone with symptoms suggesting hepatitis: jaundice, dark urine, pale stools, nausea, right upper abdominal pain, unusual tiredness
• Pregnant women, as part of routine antenatal care
• Household members and sexual partners of someone with hepatitis B
• Healthcare and laboratory workers, and anyone with a sharps injury
• People on maintenance haemodialysis, and those who have had multiple transfusions, relevant in thalassaemia and sickle cell disease
• People who have injected drugs, or shared needles, razors or unsterile tattooing and body-piercing equipment
• People with HIV infection
• Anyone with abnormal liver enzymes found incidentally
• Before starting steroids, biologics, cancer chemotherapy or rituximab-type therapy

Testing decisions rest with your doctor; this list is a guide, not a prescription.

What a hepatitis antigen test cannot detect or exclude

• It cannot tell you how your liver is doing. Antigen tests say nothing about inflammation, fibrosis or cirrhosis. Liver function tests, elastography (FibroScan or shear-wave), ultrasound and clinical assessment are needed for that.
• A negative HBsAg does not exclude hepatitis B. During the early window period after exposure, HBsAg may not yet be detectable. Occult hepatitis B can also exist with a negative HBsAg. Anti-HBc testing is required to identify past or resolved infection.
• A negative HBsAg says nothing about immunity. Immunity after vaccination or recovery is assessed with anti-HBs, not with HBsAg.
• Antigen tests do not diagnose hepatitis A or hepatitis E. These are diagnosed with IgM antibody tests. Hepatitis E is a common cause of acute jaundice in India and would be missed entirely by an HBsAg test.
• Hepatitis D is not covered. Hepatitis D testing is done only in people who are HBsAg-positive, using anti-HDV and HDV RNA.
• A negative HCV core antigen does not exclude hepatitis C, particularly at low viral loads or early after exposure. HCV RNA is more sensitive.
• It cannot separate acute from chronic hepatitis B on its own. That needs IgM anti-HBc, repeat testing over at least six months and clinical history.
• It cannot exclude non-viral causes of liver injury: alcohol, medicines including anti-tubercular therapy, herbal or AYUSH products, gym and weight-loss supplements, autoimmune hepatitis, or metabolic dysfunction-associated steatotic liver disease (MASLD, formerly called NAFLD).

A result described as "not detected" means the test did not find the target. It does not mean the condition is excluded. If your symptoms persist despite a normal or non-reactive result, return to your doctor.

Related but different examinations

Which test comes first depends on the problem. For sudden jaundice in a young adult in India, IgM anti-HEV and IgM anti-HAV often matter as much as HBsAg. For pre-operative or antenatal screening, HBsAg and anti-HCV are standard. For someone already known to have hepatitis B, HBeAg and HBV DNA guide management. No single test is superior across all situations.

How to prepare

• Fasting: generally not needed for hepatitis antigen testing. If the same sample is being used for glucose or lipids, your laboratory may ask you to fast, follow the instructions your unit gives you, as these take precedence.
• Medicines: continue prescribed medicines unless your prescriber tells you otherwise. Do not stop any medicine to prepare for this test. Tell the laboratory and your doctor about all medicines, herbal or AYUSH preparations and supplements.
• Recent vaccination: mention a recent hepatitis B vaccine dose. Transient HBsAg reactivity can occasionally be seen in samples taken very soon after vaccination.
• Hydration: normal fluid intake makes the draw easier. If you have heart failure, advanced chronic kidney disease or a prescribed fluid restriction, do not increase your fluid intake, keep to the limit your doctor has set.
• Bring earlier reports, including any previous hepatitis markers, LFTs and vaccination records.

If you have diabetes on glucose-lowering treatment

If your unit does ask you to fast for combined tests, ask the prescriber in advance how to time insulin or tablets such as sulfonylureas, since fasting can cause hypoglycaemia. Carry a glucose source.

If you are pregnant

HBsAg testing is routine in pregnancy and is not harmful. No fasting is needed. A reactive result is not a reason for panic, it allows protective steps for the baby at birth.

Children

Paediatric draws use smaller volumes and finer needles. A parent or carer should stay with the child. Tell the team if the child has a bleeding disorder or difficult veins.

Bleeding tendency or blood thinners

Tell the phlebotomist if you take anticoagulants or antiplatelets, or have haemophilia or thrombocytopenia. Firmer, longer pressure over the site is applied. Do not stop the medicine yourself.

What happens during the test

A phlebotomist cleans the skin, places a tourniquet and draws blood from a vein, usually in the front of the elbow. Pressure is applied afterwards.

How long the process takes: the blood draw itself takes about a minute; the whole visit is typically 5-15 minutes including registration and waiting. Rapid card-based HBsAg tests can give a preliminary answer within roughly 15-30 minutes, but a reactive rapid test must be confirmed by a laboratory assay. Laboratory ELISA or chemiluminescence testing is usually run in batches, and reporting time depends entirely on your laboratory's schedule, ask at the collection counter. Confirmatory or supplementary tests such as HBV DNA take longer.

Understanding your report

Hepatitis antigen results are qualitative: reactive (positive) or non-reactive (negative). Some analysers also print an index or signal-to-cut-off value. That number is specific to the assay and the laboratory; it is not a measure of how severe the infection is, and values from different laboratories cannot be compared.

• HBsAg reactive: hepatitis B virus is present. The next steps normally include repeat or confirmatory testing, IgM anti-HBc, HBeAg, anti-HBe, HBV DNA, LFTs, and screening of household and sexual contacts. Many people with chronic hepatitis B feel entirely well and never need treatment, while others do, the decision rests on viral load, enzymes and fibrosis assessment.
• HBsAg non-reactive: no detectable surface antigen at that moment. This neither confirms immunity nor excludes recent exposure.
• HBeAg reactive: generally indicates higher replication. It is interpreted only alongside HBV DNA and enzymes, and its meaning differs between the phases of chronic hepatitis B.
• HCV core antigen reactive: suggests current hepatitis C infection and should be followed up in a liver clinic. Chronic hepatitis C is treatable with direct-acting antivirals in most people, though results vary depending on individual clinical circumstances.
• Borderline or indeterminate: common enough to be expected. It usually means repeat testing on a fresh sample, sometimes with a different method.

No result should be read as a diagnosis on its own. The doctor who requested the test interprets it in your clinical context.

When results can be misleading

Falsely non-reactive (result lower than the true state)

• Window period: testing too soon after exposure, before antigen becomes detectable.
• Occult hepatitis B: very low-level infection with undetectable HBsAg.
• Viral surface-gene variants that some assays detect poorly.
• Low viral load in hepatitis C, where core antigen may be missed though HCV RNA is positive.
• Immunosuppression or after treatment, where marker patterns can be atypical.
• Pre-analytical problems: wrong tube, haemolysis, delayed transport, sample dilution from a drip-side draw.

Falsely reactive (result suggesting infection that is not there)

• Very recent hepatitis B vaccination, which can cause transient HBsAg detectability.
• Heterophile or cross-reacting antibodies, some autoimmune conditions, and rarely pregnancy-related interference.
• Rapid card tests have a higher false-reactive rate than laboratory assays; a reactive rapid test always needs laboratory confirmation.
• Clerical and labelling errors, which is why an unexpected reactive result is normally repeated before being acted on.

Risks and safety

Venous blood draw

Risks are small: brief pain, bruising, light-headedness, and rarely a small collection of blood under the skin or local infection. Bruising is more likely on anticoagulants.

Rapid point-of-care testing

Physically the same finger-prick or venous sample. The main risk is interpretive, both false-reactive and false-non-reactive results are more frequent than with laboratory assays, so rapid results are screening, not diagnosis.

Psychological and social risk

A reactive hepatitis result can cause considerable anxiety and, in India, sometimes stigma at work or in marriage negotiations. Results are confidential health data. Counselling before and after testing is part of good practice, and processing of your data should comply with the Digital Personal Data Protection Act, 2023.

Special situations

Pregnancy

HBsAg screening in pregnancy allows the newborn to receive hepatitis B vaccine and, where indicated, hepatitis B immunoglobulin soon after birth, which substantially reduces transmission. Some mothers with high viral loads are offered antiviral therapy in later pregnancy, a specialist decision. Hepatitis E in pregnancy can be severe and is a separate test.

Newborns and children

Infant HBsAg testing is timed carefully, because the birth-dose vaccine and maternal markers can confuse early interpretation. Paediatric follow-up schedules differ from adult ones.

People on dialysis or with chronic kidney disease

Periodic hepatitis B and C surveillance is standard in dialysis units, and vaccine response is often weaker, so anti-HBs levels may be checked and additional doses given.

People with HIV or on immunosuppression

Marker patterns can be atypical and reactivation risk is higher. Screening before steroids, chemotherapy or biologics is important.

Older adults

Symptoms may be vague. Multiple medicines and supplements make drug-induced liver injury an important alternative explanation for abnormal enzymes.

Thalassaemia and other transfusion-dependent conditions

Repeated transfusion, especially before universal screening improved, raises the importance of periodic hepatitis B and C testing.

Hepatitis antigen testing in the Indian context

• India carries a substantial burden of chronic hepatitis B and C, and the National Viral Hepatitis Control Programme (launched by the Ministry of Health and Family Welfare in 2018) provides free testing and treatment for hepatitis B and C at designated centres.
• Hepatitis B birth-dose vaccine and pentavalent vaccine are part of the Universal Immunisation Programme.
• Hepatitis A and E are transmitted through contaminated food and water and are frequent causes of acute jaundice, particularly in the monsoon. Neither is detected by HBsAg testing.
• Anti-tubercular therapy is widely used in India and is an important cause of drug-induced liver injury; enzymes can be abnormal with completely non-reactive viral markers.
• Herbal, AYUSH and gym or weight-loss supplements are a recognised and under-reported cause of liver injury. Declare everything you take.
• South Asians develop metabolic liver disease at lower BMI, so MASLD often coexists with, or explains, abnormal enzymes.
• Screening of blood donors for HBsAg and HCV is mandatory under blood bank regulations in India.
• Reporting of notifiable conditions and confidentiality obligations follow National Medical Commission professional conduct standards; advertising of any "cure" for hepatitis is restricted under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.

Cost and insurance in India

Costs vary widely between government facilities, standalone laboratories and hospital laboratories, and are not quoted here because they change frequently and differ by city. In general terms:

• A single rapid HBsAg screening test is the least expensive option; a laboratory ELISA or chemiluminescence HBsAg costs more.
• A combined "viral marker" or hepatitis profile costs more than a single marker.
• HBV DNA and HCV RNA molecular tests are considerably more expensive than antigen tests.
• Testing at designated National Viral Hepatitis Control Programme centres and many government hospitals is provided free or at nominal cost.

Factors that change the price: assay method (rapid vs ELISA vs CLIA), single test vs panel, urgency, home collection, city and facility type, and whether NABL-accredited processing is used.

Insurance: outpatient diagnostic tests are often not reimbursed unless your policy includes OPD or health check-up benefits. When testing is part of an admission or an approved treatment plan, cover is more likely. Confirm with your insurer or the hospital's insurance desk before testing. Indicative costs only, always confirm current charges with the facility.

Myths and facts

Frequently asked questions

Which hepatitis test should I ask for if I have jaundice?

That depends on the likely cause, so it is best decided by a doctor. Initial assessment in India often includes LFTs with SGPT/SGOT, HBsAg, anti-HCV, and IgM antibodies for hepatitis A and E. Ultrasound may be added if obstruction is suspected. Testing is guided by your history and examination.

Does a non-reactive HBsAg mean I never had hepatitis B?

No. HBsAg reflects only current detectable surface antigen. Past, resolved infection is identified by anti-HBc, and immunity by anti-HBs. A non-reactive HBsAg also cannot exclude very recent exposure, because the antigen may not yet be detectable during the window period.

How soon after exposure will the test turn positive?

Detection timing varies with the virus, the assay and the individual, so a single early test is not conclusive. After a known exposure such as a needle-stick, doctors follow a structured schedule of repeat testing over weeks to months. Post-exposure prophylaxis decisions are urgent and should not wait for results.

Is the hepatitis antigen test painful?

Most people feel only a brief prick and mild pressure. Some have minor bruising afterwards. Light-headedness happens occasionally, so mention it beforehand if you have fainted during blood tests previously and stay seated for a few minutes after the draw.

Can chronic hepatitis B be treated?

Chronic hepatitis B can usually be controlled with antiviral medicines, and many people need only monitoring rather than treatment. Long-term suppression reduces complications. Chronic hepatitis C can often be cleared with direct-acting antivirals. Results vary depending on individual clinical circumstances and require specialist assessment.

My HBsAg is reactive but I feel completely well. Is that possible?

Yes, and it is common. Chronic hepatitis B is frequently silent for years. Feeling well does not remove the need for assessment, because monitoring of viral load, liver enzymes and fibrosis guides whether treatment is required and protects contacts through vaccination.

What is the difference between HBsAg and HBeAg?

HBsAg answers whether hepatitis B virus is present, and is used for screening and diagnosis. HBeAg indicates a higher-replication phase and is used for staging and monitoring in people already known to be HBsAg-positive. HBeAg is not a screening test and is interpreted with HBV DNA.

Should my family be tested if my result is reactive?

Testing and vaccination of household members and sexual partners is generally advised for hepatitis B, and your doctor will advise on who should be checked and with which markers. For hepatitis C, contacts who have had blood exposure are usually tested. Counselling helps decide the scope.

Can I donate blood after a reactive hepatitis result?

No. In India, blood donors are screened for HBsAg and hepatitis C, and a reactive result permanently defers donation. This protects recipients. You can still receive full medical care and, in most cases, effective treatment or monitoring for your own condition.

Sources

• World Health Organization, Guidelines on hepatitis B and C testing, and consolidated guidance on chronic hepatitis B and C
• Ministry of Health and Family Welfare, Government of India, National Viral Hepatitis Control Programme (launched 2018), operational and training guidelines
• Indian National Association for Study of the Liver (INASL), consensus statements on hepatitis B and C
• National Blood Transfusion Council / Drugs and Cosmetics Rules, mandatory donor screening requirements
• Digital Personal Data Protection Act, 2023, handling of personal health data
• Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954